466 related articles for article (PubMed ID: 31831021)
1. Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects.
Kamarudin MNA; Sarker MMR; Zhou JR; Parhar I
J Exp Clin Cancer Res; 2019 Dec; 38(1):491. PubMed ID: 31831021
[TBL] [Abstract][Full Text] [Related]
2. Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Thent ZC; Zaidun NH; Azmi MF; Senin MI; Haslan H; Salehuddin R
Curr Drug Targets; 2017; 18(6):734-750. PubMed ID: 27919208
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
[TBL] [Abstract][Full Text] [Related]
4. Anticancer mechanisms of metformin: A review of the current evidence.
Zhao B; Luo J; Yu T; Zhou L; Lv H; Shang P
Life Sci; 2020 Aug; 254():117717. PubMed ID: 32339541
[TBL] [Abstract][Full Text] [Related]
5. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
Pácal L; Kaňková K
Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
[TBL] [Abstract][Full Text] [Related]
6. Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Christodoulou MI; Scorilas A
Curr Med Chem; 2017; 24(1):14-56. PubMed ID: 27604091
[TBL] [Abstract][Full Text] [Related]
7. Metformin suppresses CRC growth by inducing apoptosis via ADORA1.
Lan B; Zhang J; Zhang P; Zhang W; Yang S; Lu D; Li W; Dai Q
Front Biosci (Landmark Ed); 2017 Jan; 22(2):248-257. PubMed ID: 27814614
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways: preclinical models and clinical trials with metformin in breast cancer.
Thompson AM
Clin Cancer Res; 2014 May; 20(10):2508-15. PubMed ID: 24682417
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma.
Ding J; Zhu YT; Yang L; Tang J; Wang YY; Chen Y; Cheng K; Liu JQ; Zhang YN; Li ZK; Du Y; Qiu M; Liu JY
Carcinogenesis; 2018 Mar; 39(3):493-502. PubMed ID: 29390122
[TBL] [Abstract][Full Text] [Related]
10. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
11. How far along are we in revealing the connection between metformin and colorectal cancer?
Berkovic MC; Mikulic D; Bilic-Curcic I; Mrzljak A
World J Gastroenterol; 2021 Apr; 27(14):1362-1368. PubMed ID: 33911461
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
[TBL] [Abstract][Full Text] [Related]
13. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
[TBL] [Abstract][Full Text] [Related]
14. New perspective for an old antidiabetic drug: metformin as anticancer agent.
Leone A; Di Gennaro E; Bruzzese F; Avallone A; Budillon A
Cancer Treat Res; 2014; 159():355-76. PubMed ID: 24114491
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
[TBL] [Abstract][Full Text] [Related]
16. Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts.
Mohamed Suhaimi NA; Phyo WM; Yap HY; Choy SHY; Wei X; Choudhury Y; Tan WJ; Tan LAPY; Foo RSY; Tan SHS; Tiang Z; Wong CF; Koh PK; Tan MH
Mol Cancer Ther; 2017 Sep; 16(9):2035-2044. PubMed ID: 28533437
[TBL] [Abstract][Full Text] [Related]
17. Is it time to test biguanide metformin in the treatment of melanoma?
Cerezo M; Tomic T; Ballotti R; Rocchi S
Pigment Cell Melanoma Res; 2015 Jan; 28(1):8-20. PubMed ID: 24862830
[TBL] [Abstract][Full Text] [Related]
18. Metformin as an antitumor agent in cancer prevention and treatment.
Li D
J Diabetes; 2011 Dec; 3(4):320-7. PubMed ID: 21631893
[TBL] [Abstract][Full Text] [Related]
19. A new contribution for an old drug: Prospect of metformin in colorectal oncotherapy.
Jiang S; Lu Q
J Cancer Res Ther; 2021 Dec; 17(7):1608-1617. PubMed ID: 35381729
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.
Ala M
Curr Diabetes Rev; 2022; 18(8):e051121197762. PubMed ID: 34749618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]